JPML Asked to Consider Arguments for Transfer of Abilify Compulsive Behavior Cases
June 27, 2016
WASHINGTON, D.C. — Plaintiffs have asked the U.S. Judicial Panel on Multidistrict Litigation for argument and consideration to be scheduled regarding a motion to transfer all federal Abilify compulsive behavior cases to Florida for coordinated and consolidated pretrial hearings.
On June 24, Denise and Brad Miley — with the consent of other plaintiffs and defendants Bristol-Myers Squibb Co., Otsuka Pharmaceutical Co. Ltd., and Otsuka America Pharmaceutical Inc. — argued that if the panel does not consider the argument during its July 28 hearing, the parties’ joint motion to transfer will not be heard until Sept. 29.
The joint motion …